Sökning: WFRF:(Happonen Juha Matti) > Pharmacological and...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03781naa a2200505 4500 | |
001 | oai:DiVA.org:uu-205633 | |
003 | SwePub | |
008 | 130821s2013 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2056332 URI |
024 | 7 | a https://doi.org/10.1093/europace/eut0822 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Brugada, Josep4 aut |
245 | 1 0 | a Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population :b EHRA and AEPC-Arrhythmia Working Group joint consensus statement |
264 | c 2013-07-12 | |
264 | 1 | b Oxford University Press (OUP),c 2013 |
338 | a print2 rdacarrier | |
520 | a In children with structurally normal hearts, the mechanisms of arrhythmias are usually the same as in the adult patient. Some arrhythmias are particularly associated with young age and very rarely seen in adult patients. Arrhythmias in structural heart disease may be associated either with the underlying abnormality or result from surgical intervention. Chronic haemodynamic stress of congenital heart disease (CHD) might create an electrophysiological and anatomic substrate highly favourable for re-entrant arrhythmias.As a general rule, prescription of antiarrhythmic drugs requires a clear diagnosis with electrocardiographic documentation of a given arrhythmia. Risk-benefit analysis of drug therapy should be considered when facing an arrhythmia in a child. Prophylactic antiarrhythmic drug therapy is given only to protect the child from recurrent supraventricular tachycardia during this time span until the disease will eventually cease spontaneously. In the last decades, radiofrequency catheter ablation is progressively used as curative therapy for tachyarrhythmias in children and patients with or without CHD. Even in young children, procedures can be performed with high success rates and low complication rates as shown by several retrospective and prospective paediatric multi-centre studies. Three-dimensional mapping and non-fluoroscopic navigation techniques and enhanced catheter technology have further improved safety and efficacy even in CHD patients with complex arrhythmias.During last decades, cardiac devices (pacemakers and implantable cardiac defibrillator) have developed rapidly. The pacing generator size has diminished and the pacing leads have become progressively thinner. These developments have made application of cardiac pacing in children easier although no dedicated paediatric pacing systems exist. | |
653 | a Kardiologi | |
653 | a Cardiology | |
700 | 1 | a Blom, Nico4 aut |
700 | 1 | a Sarquella-Brugada, Georgia4 aut |
700 | 1 | a Blomström-Lundqvist, Carinau Uppsala universitet,Kardiologi-arrytmi4 aut0 (Swepub:uu)carinabl |
700 | 1 | a Deanfield, John4 aut |
700 | 1 | a Janousek, Jan4 aut |
700 | 1 | a Abrams, Dominic4 aut |
700 | 1 | a Bauersfeld, Urs4 aut |
700 | 1 | a Brugada, Ramon4 aut |
700 | 1 | a Drago, Fabrizio4 aut |
700 | 1 | a de Groot, Natasja4 aut |
700 | 1 | a Happonen, Juha-Matti4 aut |
700 | 1 | a Hebe, Joachim4 aut |
700 | 1 | a Yen Ho, Siew4 aut |
700 | 1 | a Marijon, Eloi4 aut |
700 | 1 | a Paul, Thomas4 aut |
700 | 1 | a Pfammatter, Jean-Pierre4 aut |
700 | 1 | a Rosenthal, Eric4 aut |
710 | 2 | a Uppsala universitetb Kardiologi-arrytmi4 org |
773 | 0 | t Europaced : Oxford University Press (OUP)g 15:9, s. 1337-1382q 15:9<1337-1382x 1099-5129x 1532-2092 |
856 | 4 | u https://academic.oup.com/europace/article-pdf/15/9/1337/17860965/eut082.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-205633 |
856 | 4 8 | u https://doi.org/10.1093/europace/eut082 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.